Clinical Cardiology

View the latest content related to this topic

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

L.A. McKeown

July 24, 2025

Slides

See all

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation ACC 2025

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 29, 2025

Presentation ACC 2025

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Presenter: Keyvan Karkouti

March 29, 2025

Presentation Controversies and Advances 2025

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Presenter: Kalyanam Shivkumar

January 30, 2025

Presentation Controversies and Advances 2025

Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net!

Presenter: Richard J. Auchus

January 30, 2025

News

See all

News Conference News SCCT 2025

Air Pollution in Canada Ups CAC, Total Plaque, and Obstructive CAD

By Yael L. Maxwell

July 25, 2025

News Daily News

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

By Todd Neale

July 25, 2025

News Conference News SCCT 2025

Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges

By Yael L. Maxwell

July 25, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

By L.A. McKeown

July 24, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

By Todd Neale

July 24, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Clinical Cardiology

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Slides

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net!

News

Air Pollution in Canada Ups CAC, Total Plaque, and Obstructive CAD

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Clinical Cardiology

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content